RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in RVL Pharmaceuticals plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −10 vs. Q3 2022
- Shares held
- 25.1M
- +1.08M (+4.5%) vs. Q3 2022
- Total value
- $28.0M
- −$22.5M (−44.5%) vs. Q3 2022
- New holders
- 1
- 13 more added
- Sold out
- 11
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $16.4M | 6.87% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 3,000,000 | $3.24M | 1.19% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,801,864 | $2.02M | 0.67% | +1,062,333+143.6% | Added |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $1.82M | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 1,096,633 | $1.23M | 0.00% | −76,571−6.5% | Reduced |
| Renaissance Technologies LLC | 715,215 | $801.0K | 0.00% | −56,792−7.4% | Reduced |
| Worth Venture Partners, LLC | 455,960 | $510.7K | 0.30% | +270,313+145.6% | Added |
| Geode Capital Management, LLC | 307,266 | $344.0K | 0.00% | +2,884+0.9% | Added |
| Vanguard Group Inc | 246,353 | $275.9K | 0.00% | +23,918+10.8% | Added |
| BlackRock Inc. | 202,642 | $227.0K | 0.00% | +1,223+0.6% | Added |
| Millennium Management LLC | 173,947 | $195.0K | 0.00% | +11,719+7.2% | Added |
| Susquehanna International Group, LLP | 120,906 | $135.4K | 0.00% | +106,243+724.6% | Added |
| Marietta Wealth Management, LLC | 120,000 | $134.4K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 96,151 | $108.0K | 0.00% | +9,790+11.3% | Added |
| Titleist Asset Management, Ltd. | 92,503 | $103.6K | 0.02% | −5,648−5.8% | Reduced |
| State Street Corp | 78,687 | $88.1K | 0.00% | +6,500+9.0% | Added |
| Northern Trust Corp | 72,899 | $81.6K | 0.00% | +8,427+13.1% | Added |
| Citadel Advisors LLC | 47,143 | $52.8K | 0.00% | +25,582+118.6% | Added |
| Virtu Financial LLC | 39,818 | $45.0K | 0.01% | +16,983+74.4% | Added |
| Insight Advisors, LLC | 37,823 | $43.5K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 31,500 | $35.3K | 0.00% | +31,500 | New |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $33.1K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 23,317 | $26.1K | 0.00% | +20,468+718.4% | Added |
| Atria Wealth Solutions, Inc. | 23,000 | $25.8K | 0.00% | −4,000−14.8% | Reduced |
| Wells Fargo & Company | 16,723 | $18.7K | 0.00% | −6,994−29.5% | Reduced |
| Two Sigma Advisers, LP | 14,100 | $15.8K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,322 | $14.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,078 | $13.5K | 0.00% | 00.0% | Unchanged |
| SFMG, LLC | 10,000 | $11.2K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $11.2K | 0.00% | 00.0% | Unchanged |
| Tower View Investment Management & Research LLC | 4,100 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,720 | $1.93K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,382 | $1.55K | 0.00% | −10,012−87.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,187 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 7 | $8 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −276,428−100.0% | Sold out |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,298−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,483−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,927−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −8,356−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −1,650−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −306−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| Tilia Fiduciary Partners, Inc. | 0 | $0 | 0.00% | −435−100.0% | Sold out |